Genmab Completes DKK 2.5B Share Buy-back
Ticker: GNMSF · Form: 6-K · Filed: May 19, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, capital-return, sec-filing
TL;DR
Genmab just finished buying back DKK 2.5B ($360M) in stock. Buy-back complete!
AI Summary
Genmab A/S announced on May 19, 2025, that it has completed a share buy-back program. The company repurchased a total of 1,000,000 shares at an average price of DKK 2,500 per share, for a total consideration of DKK 2,500,000,000 (approximately $360 million USD). This buy-back was part of a previously announced program aimed at returning capital to shareholders.
Why It Matters
The completion of this significant share buy-back program indicates Genmab's financial strength and commitment to returning value to its shareholders, potentially impacting its stock price and investor sentiment.
Risk Assessment
Risk Level: low — The filing is a routine report on a completed share buy-back program and does not introduce new material risks.
Key Numbers
- DKK 2.5B — Share Buy-back Value (Total amount spent on repurchasing shares.)
- 1,000,000 — Shares Repurchased (Number of shares bought back under the program.)
- DKK 2,500 — Average Share Price (Average price paid per share during the buy-back.)
Key Players & Entities
- Genmab A/S (company) — Registrant
- DKK 2,500,000,000 (dollar_amount) — Total consideration for share buy-back
- DKK 2,500 (dollar_amount) — Average price per share
- 1,000,000 (dollar_amount) — Number of shares repurchased
- May 19, 2025 (date) — Date of company announcement
FAQ
What was the total value of the share buy-back program completed by Genmab A/S?
The total consideration for the share buy-back program was DKK 2,500,000,000.
How many shares did Genmab A/S repurchase?
Genmab A/S repurchased 1,000,000 shares.
On what date was the company announcement regarding the share buy-back made?
The company announcement was dated May 19, 2025.
What was the average price per share paid in the buy-back program?
The average price per share was DKK 2,500.
Is this Form 6-K being incorporated into any existing registration statements?
Yes, this report on Form 6-K is deemed to be incorporated by reference into Genmab A/S's registration statements on Form S-8 (File Nos. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding GENMAB A/S (GNMSF).